[go: up one dir, main page]

FI871958A7 - Menetelmä mikrokapseleiden valmistamiseksi - Google Patents

Menetelmä mikrokapseleiden valmistamiseksi

Info

Publication number
FI871958A7
FI871958A7 FI871958A FI871958A FI871958A7 FI 871958 A7 FI871958 A7 FI 871958A7 FI 871958 A FI871958 A FI 871958A FI 871958 A FI871958 A FI 871958A FI 871958 A7 FI871958 A7 FI 871958A7
Authority
FI
Finland
Prior art keywords
preparing microcapsules
microcapsules
preparing
Prior art date
Application number
FI871958A
Other languages
English (en)
Swedish (sv)
Other versions
FI871958A0 (fi
FI92647C (fi
FI92647B (fi
Inventor
Bo Magnus Ekman
Kaore Viktor Larsson
Aoke Rikard Lindahl
Ulf Sven Erik Rothman
Original Assignee
Biogram Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogram Ab filed Critical Biogram Ab
Publication of FI871958A0 publication Critical patent/FI871958A0/fi
Publication of FI871958A7 publication Critical patent/FI871958A7/fi
Application granted granted Critical
Publication of FI92647B publication Critical patent/FI92647B/fi
Publication of FI92647C publication Critical patent/FI92647C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B01J13/06—Making microcapsules or microballoons by phase separation
    • B01J13/08—Simple coacervation, i.e. addition of highly hydrophilic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2989—Microcapsule with solid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Birds (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Cosmetics (AREA)
  • Formation And Processing Of Food Products (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Developing Agents For Electrophotography (AREA)
FI871958A 1985-10-28 1987-05-04 Menetelmä mikrokapseleiden valmistamiseksi FI92647C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE8505086 1985-10-28
SE8505086A SE462894B (sv) 1985-10-28 1985-10-28 Mikrokapslar, foerfarande foer framstaellning daerav samt anvaendning
PCT/SE1986/000451 WO1987002582A1 (en) 1985-10-28 1986-10-06 Micro-capsules
SE8600451 1986-10-06

Publications (4)

Publication Number Publication Date
FI871958A0 FI871958A0 (fi) 1987-05-04
FI871958A7 true FI871958A7 (fi) 1987-05-04
FI92647B FI92647B (fi) 1994-09-15
FI92647C FI92647C (fi) 1994-12-27

Family

ID=20361951

Family Applications (1)

Application Number Title Priority Date Filing Date
FI871958A FI92647C (fi) 1985-10-28 1987-05-04 Menetelmä mikrokapseleiden valmistamiseksi

Country Status (19)

Country Link
US (1) US4931284A (fi)
EP (1) EP0224457B1 (fi)
JP (1) JPS63501150A (fi)
KR (1) KR940000230B1 (fi)
AT (1) ATE50158T1 (fi)
AU (1) AU586513B2 (fi)
CA (1) CA1286928C (fi)
DE (1) DE3668792D1 (fi)
DK (1) DK175157B1 (fi)
ES (1) ES2013724B3 (fi)
FI (1) FI92647C (fi)
GR (1) GR3000410T3 (fi)
IL (1) IL80125A (fi)
IN (1) IN165089B (fi)
NZ (1) NZ217929A (fi)
PH (1) PH21729A (fi)
SE (1) SE462894B (fi)
WO (1) WO1987002582A1 (fi)
ZA (1) ZA867288B (fi)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1338736C (fr) * 1986-12-05 1996-11-26 Roger Baurain Microcristaux comportant une substance active presentant une affinite pour les phospholipides, et au moins un phospholipide, procede de preparation
FR2620028B2 (fr) * 1986-12-05 1994-02-25 Ire Celltarg Sa Procede de preparation de microcristaux comportant a titre de substance active, notamment de l'amphotericine b, microcristaux obtenus et composition pharmaceutique en comprenant
FR2628317B1 (fr) * 1988-03-09 1991-11-08 Lvmh Rech Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un extrait de scutellaria, ou au moins un flavonoide tel que baicaleine ou baicaline et composition cosmetique ou pharmaceutique, notamment dermatologique, a activite anti-allergique, anti-inflammatoire ou anti-vieillissement, l'incorporant
US5174988A (en) * 1989-07-27 1992-12-29 Scientific Development & Research, Inc. Phospholipid delivery system
US5213810A (en) * 1990-03-30 1993-05-25 American Cyanamid Company Stable compositions for parenteral administration and method of making same
FR2660554B1 (fr) * 1990-04-05 1992-07-03 Oreal Composition cosmetique ou dermo-pharmaceutique aqueuse contenant en suspension des spherouides hydrates d'une substance lipidique hydrophile.
GB9021061D0 (en) * 1990-09-27 1990-11-07 Unilever Plc Encapsulating method and products containing encapsulated material
DK0558523T3 (da) * 1990-11-23 1994-11-28 Unilever Plc Anvendelse af mesomorfe faser i næringsmiddelprodukter
JP3609827B2 (ja) * 1991-06-26 2005-01-12 ヤマノウチ ユーロープ ベスローテン フェンノートシャップ 非極性基剤における小胞
FR2681247B1 (fr) * 1991-09-17 1993-12-03 Oreal Composition pharmaceutique pour application topique contenant du dithranol et procede de preparation.
CA2082561A1 (en) * 1991-11-12 1993-05-13 Francis J. Leng Antiperspirant materials and compositions
US6368653B1 (en) 1992-03-05 2002-04-09 Van Den Berghfoods Co., Division Of Conopco, Inc. Use of mesomorphic phases in food products
US5620734A (en) * 1992-03-05 1997-04-15 Van Den Bergh Foods Co., Division Of Conopco, Inc. Spreads and other products including mesomorphic phases
US5785976A (en) * 1993-03-05 1998-07-28 Pharmacia & Upjohn Ab Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof
US5885486A (en) * 1993-03-05 1999-03-23 Pharmaciaand Upjohn Ab Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof
US6090925A (en) 1993-03-09 2000-07-18 Epic Therapeutics, Inc. Macromolecular microparticles and methods of production and use
ATE163230T1 (de) * 1993-03-09 1998-02-15 Epic Therapeutics Inc Makromolekulare mikropartikel und verfahren zu ihrer herstellung
US20050181976A1 (en) * 1993-05-10 2005-08-18 Ekwuribe Nnochiri N. Amphiphilic oligomers
FR2715069B1 (fr) * 1994-01-20 1996-04-05 Rene Laversanne Procédé pour améliorer la rémanence d'une odeur.
DE4414755C2 (de) * 1994-04-27 2000-11-16 Lohmann Therapie Syst Lts Kollagenzubereitung zur gesteuerten Abgabe von Wirkstoffen, Verfahren und Verwendung
US6638621B2 (en) * 2000-08-16 2003-10-28 Lyotropic Therapeutics, Inc. Coated particles, methods of making and using
ATE246039T1 (de) 1997-09-09 2003-08-15 Select Release L C Beschichtete teilchen, methode zu ihrer herstellung und verwendung
DE19748796A1 (de) * 1997-11-05 1999-05-06 Beiersdorf Ag Verfahren zur Herstellung von Liposomen
US6262152B1 (en) 1998-10-06 2001-07-17 E. I. Du Pont De Nemours And Company Particles dispersed w/polymer dispersant having liquid soluble and cross-linkable insoluble segments
US6676930B2 (en) * 1999-11-28 2004-01-13 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
US6156294A (en) * 1999-11-28 2000-12-05 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
US20020153508A1 (en) * 2000-06-29 2002-10-24 Lynch Matthew Lawrence Cubic liquid crystalline compositions and methods for their preparation
KR100489318B1 (ko) * 2001-08-25 2005-05-17 이원목 비타민 마이크로캡슐을 포함하는 섬유 유연제 조성물
US6808715B2 (en) 2001-11-09 2004-10-26 Or-Le-Or Ltd. Wrinkle cream
DE10156794B4 (de) * 2001-11-19 2006-05-18 Medigene Ag Arzneimittel zur Behandlung von Warzen
IL161625A0 (en) 2001-11-19 2004-09-27 Medigene Ag Medicament for the treatment of viral skin and tumour diseases
US20030232091A1 (en) * 2002-06-17 2003-12-18 Adi Shefer Stabilized retinol for cosmetic dermatological, and pharmaceutical compositions, and use thereof
RU2331424C2 (ru) * 2002-12-13 2008-08-20 Джеготек Аг Топический состав, содержащий наночастицы спиронолактона
BR0215979A (pt) * 2002-12-13 2005-11-01 Jagotec Ag Formulação de espironolactona nanoparticulada tópica, uso de nanossuspensões de espironolactona, sistema de rede cristalina, e, processo para a preparação de uma formulação de espironolactona nanoparticulada tópica
US20050079235A1 (en) * 2003-10-09 2005-04-14 Eggert Stockfleth Use of a polyphenol for the treatment of actinic keratosis
CA2541405C (en) * 2003-10-09 2014-07-29 Medigene Ag The use of a polyphenol for the treatment of a cancerous or pre-cancerous lesion of the skin
FR2865911B1 (fr) 2004-02-06 2008-01-25 Oreal Dispositif de conditionnement et d'application comportant un organe d'essorage
US8075910B2 (en) * 2004-05-20 2011-12-13 Pbm Pharmaceuticals, Inc. Oral compositions comprising edible oils and vitamins and/or minerals and methods for making oral compositions
US8535709B2 (en) * 2004-12-13 2013-09-17 Southeastern Medical Technologies, Llc Agents for controlling biological fluids and methods of use thereof
US20070059350A1 (en) * 2004-12-13 2007-03-15 Kennedy John P Agents for controlling biological fluids and methods of use thereof
US20060127437A1 (en) * 2004-12-13 2006-06-15 Misty Anderson Kennedy Semisolid system and combination semisolid, multiparticulate system for sealing tissues and/or controlling biological fluids
US7125954B2 (en) * 2005-01-27 2006-10-24 General Electric Company Method for producing polyether polymers
GB201118198D0 (en) 2011-10-21 2011-12-07 Jagotec Ag Improvements in or relating to organic compounds
GB201118193D0 (en) 2011-10-21 2011-12-07 Jagotec Ag Improvements in or relating to oranic compounds
US9530532B2 (en) 2014-08-22 2016-12-27 Abb Schweiz Ag Hybrid conductor with circumferential conducting layers

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL271010A (fi) * 1960-11-04
DK116528A (fi) * 1966-09-30
DE2249552A1 (de) * 1971-10-12 1973-05-30 Inchema S A Verfahren zur inkapsulation von insbesondere wasserloeslichen verbindungen
US4371736A (en) * 1981-03-27 1983-02-01 E. I. Du Pont De Nemours And Company Herbicidal pyridinyloxy(pyrimidinyloxy)benzenes
EP0084052A1 (en) * 1981-07-23 1983-07-27 Arthur D. Little, Inc. Micellular drug delivery system
WO1984000906A1 (en) * 1982-08-30 1984-03-15 Labtest Equipment Company S E Nebulizer
US4622219A (en) * 1983-06-17 1986-11-11 Haynes Duncan H Method of inducing local anesthesia using microdroplets of a general anesthetic

Also Published As

Publication number Publication date
FI871958A0 (fi) 1987-05-04
SE8505086L (sv) 1987-04-29
WO1987002582A1 (en) 1987-05-07
ES2013724B3 (es) 1990-06-01
ZA867288B (en) 1987-05-27
DK175157B1 (da) 2004-06-21
KR870700346A (ko) 1987-12-28
DK327887A (da) 1987-06-26
NZ217929A (en) 1989-04-26
JPS63501150A (ja) 1988-04-28
EP0224457A1 (en) 1987-06-03
PH21729A (en) 1988-02-10
SE462894B (sv) 1990-09-17
US4931284A (en) 1990-06-05
DK327887D0 (da) 1987-06-26
IL80125A (en) 1990-07-26
FI92647C (fi) 1994-12-27
IN165089B (fi) 1989-08-12
AU6526586A (en) 1987-05-19
IL80125A0 (en) 1986-12-31
EP0224457B1 (en) 1990-02-07
CA1286928C (en) 1991-07-30
SE8505086D0 (sv) 1985-10-28
FI92647B (fi) 1994-09-15
KR940000230B1 (ko) 1994-01-12
ATE50158T1 (de) 1990-02-15
DE3668792D1 (de) 1990-03-15
AU586513B2 (en) 1989-07-13
GR3000410T3 (en) 1991-06-28

Similar Documents

Publication Publication Date Title
FI871958A7 (fi) Menetelmä mikrokapseleiden valmistamiseksi
KR860005811A (ko) 티아졸리딘디온 유도체의 제조방법
FI864560L (fi) Menetelmä uusien insuliinijohdannaisten valmistamiseksi
FI863597A7 (fi) Menetelmä tetrafluoribentsoehapon valmistamiseksi.
FI863776A7 (fi) Menetelmä 7-aminomitosaanijohdannaisten valmistamiseksi.
ES551807A0 (es) Procedimiento para preparar piridinil acilhidrazonas
FI871670L (fi) Menetelmä osseiini-hydroksiapatiittiyhdisteen valmistamiseksi
KR860004922A (ko) N-포르밀-α-아스파르틸페닐알라닌의 제조방법
FI891362A7 (fi) Menetelmä uusien alkanofenonien valmistamiseksi
KR870001175A (ko) 5-치환된-6-아미노피리미딘 유도체의 제조방법
FI870050A0 (fi) Menetelmä hajunpoistoaineen valmistamiseksi
KR880700092A (ko) 정련 방법
FI891871A7 (fi) Menetelmä mikrokapseleiden valmistamiseksi
KR860005812A (ko) 4,4-디알킬-2-아제티디논의 제조 방법
FI855131A7 (fi) Menetelmä 8 -asyyliaminoergoliinin valmistamiseksi
FI864893A7 (fi) Menetelmä uusien tetrahydroisokinoliinijohdannaisten valmistamiseksi.
ES555384A0 (es) Procedimiento de preparar diosmina
FI882895A7 (fi) Menetelmä 2-kinoksaliinien valmistamiseksi
FI864484A7 (fi) Menetelmä uretaanien valmistamiseksi.
FI882314L (fi) Halogeeni-imidien valmistusmenetelmä
KR860004941A (ko) 아실-락탐화합물을 제조하는 방법
DK229986A (da) Fremgangsmaade til fremstilling af 2-thiocromenylidenethylacetoacetater
RO90104A2 (ro) Metoda pentru termoanaliza
KR860005805A (ko) 신규한 8α-아실아미노에르고린의 제조방법
RO90707A2 (ro) Procedeu pentru obtinerea azobisizobutironitrilului

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: JAGOTEC AG

MA Patent expired